Annual Report for the year ended 30 June 2009


		OUR GROUP IN BRIEF Our global footprint Healthcare for life Group overview Highlights, achievements and key facts Financial highlights Sustainability highlights and recognition Aspen as an investment Our Group at a glance Ten-year review Therapeutic catagories OUR REVIEWS Chairman’s report Group Chief Executive’s report Financial review BUSINESS REVIEW South African business International business SUSTAINABILITY AND GOVERNANCE Directorate Sustainability report Transformation report Corporate social investment report Value added statement Corporate governance report GROUP FINANCIAL STATEMENTS Statement of responsibility by the Board of Directors Independent auditors’ report Certificate of the Company Secretary Directors’ report Group statement of financial position Group statement of comprehensive income Group statement of changes in equity Group statement of cash flows Group notes to statement of cash flows Accounting policies Significant judgements and estimates Finalisation of PharmaLatina acquisition accounting Notes to the Group annual financial statements Company statement of financial position Company statement of comprehensive income Company statement of changes in equity Company statement of cash flows Company notes to the statement of cash flows Notes to the Company annual financial statements Group currency conversion (unaudited) – annexure 1 Share statistics (unaudited) – annexure 2 Specific repurchase of treasury shares Notice of agm Form of proxy Administration and shareholders' diary Abbreviations and definitions Products depicted

|

|

|

|

Aspen as an investment

1
2
3

VISION AND MISSION

To deliver value to all our stakeholders as a responsible corporate citizen that provides quality, affordable medicines globally.

VALUES

Integrity
Innovation
Excellence
Commitment
Teamwork

STRATEGIC OBJECTIVES

To maintain our position as the leading provider of pharmaceuticals in South Africa.
To be the leading provider of pharmaceuticals in sub-Saharan Africa through the GSK/Aspen collaboration.
To rapidly grow our market share in Latin America.
To outperform the market in Australia.
To strive for continuous improvement in every business.
To extend our presence into new markets.
To provide patients with high quality medicines at competitive prices.
To achieve a strategic advantage through our production capabilities.
To continuously increase and improve our offering to healthcare professionals and patients through a prolific product pipeline.
To provide a safe, challenging and rewarding environment for our employees.
To deliver excellent service to our customers.
To practise good corporate governance.
To achieve superior returns on investment for our shareholders.

Striving for excellence

Back to top

1
2
3